These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2649284

  • 1. Immunocytochemical analysis of cellular responses to BCG.
    Nibbering PH, van der Heide GA, van Furth R.
    Clin Exp Immunol; 1989 Jan; 75(1):147-54. PubMed ID: 2649284
    [Abstract] [Full Text] [Related]

  • 2. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 3. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice.
    Kaneko H, Yamada H, Mizuno S, Udagawa T, Kazumi Y, Sekikawa K, Sugawara I.
    Lab Invest; 1999 Apr 13; 79(4):379-86. PubMed ID: 10211990
    [Abstract] [Full Text] [Related]

  • 4. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep 13; 27(9):611-6. PubMed ID: 15498274
    [Abstract] [Full Text] [Related]

  • 5. Increased activity of FIM in serum of mice during a Mycobacterium bovis (BCG) infection.
    Sluiter W, Nibbering PH, Van Furth R, Annema A, Elzenga-Claasen I, Van Hemsbergen-Oomens LW, Van der Voort Van der Kleij-Van Andel A.
    Immunology; 1990 Jul 13; 70(3):327-31. PubMed ID: 2199369
    [Abstract] [Full Text] [Related]

  • 6. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
    van Dissel JT, Stikkelbroeck JJ, van den Barselaar MT, Sluiter W, Leijh PC, van Furth R.
    J Immunol; 1987 Sep 01; 139(5):1665-72. PubMed ID: 2957432
    [Abstract] [Full Text] [Related]

  • 7. Macrophages in bronchoalveolar lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice.
    Nibbering PH, van der Heide A, van Furth R.
    J Pathol; 1989 Mar 01; 157(3):253-61. PubMed ID: 2926565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D, Akuffo H, Pawlowski A, Haile M, Schön T, Britton S.
    Vaccine; 2005 Feb 03; 23(11):1326-34. PubMed ID: 15661380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL, Tsenova L, Murray PJ, Freeman S, Bergtold A, Chiriboga L, Kaplan G.
    Microb Pathog; 2000 Sep 03; 29(3):175-85. PubMed ID: 10968949
    [Abstract] [Full Text] [Related]

  • 13. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
    Gros P, Skamene E, Forget A.
    J Immunol; 1983 Oct 03; 131(4):1966-72. PubMed ID: 6311901
    [Abstract] [Full Text] [Related]

  • 14. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I, Radzioch D, Skamene E.
    Immunology; 1994 Apr 03; 81(4):618-25. PubMed ID: 8039813
    [Abstract] [Full Text] [Related]

  • 15. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ.
    North RJ, Izzo AA.
    Am J Pathol; 1993 Jun 03; 142(6):1959-66. PubMed ID: 8506962
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
    Teruya K, Kawakami K, Tohyama M, Saito A.
    Kekkaku; 1995 Apr 03; 70(4):293-9. PubMed ID: 7760538
    [Abstract] [Full Text] [Related]

  • 17. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA, Mashruwala MA, Smith AK, Lindsey DR, Wetsel RA, Haviland DL, Hunter RL, Jagannath C.
    J Leukoc Biol; 2007 Oct 03; 82(4):956-67. PubMed ID: 17675563
    [Abstract] [Full Text] [Related]

  • 18. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.
    Eur J Immunol; 2008 Mar 03; 38(3):695-705. PubMed ID: 18266274
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM, Sampaio EP, de Moraes MO, Albuquerque EC, Castro AP, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2000 Jun 03; 68(2):156-66. PubMed ID: 11036496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.